Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
19,704.33
+30.00
0.15%
Nifty
5,983.55
+16.50
0.28%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Marksans Pharma Ltd
BSE: 524404 | NSE: MARKSANS | ISIN: INE750C01026
Market Cap: [Rs.Cr.] 151 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs
Discuss this stock
Company News
Mar 04, 2013
11:45
Marksans Pharma enters into a settlement agreement with holders of FCCBs
Feb 16, 2013
11:59
Marksans Pharma reports net profit of Rs 7.90 crore in the December 2012 quarter
Dec 14, 2012
17:07
Marksans Pharma allots equity shares
Dec 10, 2012
12:06
Marksans Pharma to consider conversion of warrants
Nov 12, 2012
21:42
Marksans Pharma reports net profit of Rs 14.40 crore in the September 2012 quarter
Aug 14, 2012
19:55
Marksans Pharma reports net loss of Rs 19.73 crore in the June 2012 quarter
May 30, 2012
09:05
Marksans Pharma reports net loss of Rs 118.04 crore in the March 2012 quarter
Feb 13, 2012
22:45
Marksans Pharma reports net loss of Rs 60.54 crore in the December 2011 quarter
Nov 14, 2011
21:30
Marksans Pharma reports net loss of Rs 2.18 crore in the September 2011 quarter
Oct 25, 2011
17:07
Marksans Pharma allots warrants
Oct 07, 2011
12:23
Marksans Pharma appoints whole-time director
Oct 05, 2011
16:29
Marksans Pharma appoints director
Aug 26, 2011
17:26
Marksans Pharma to issue warrants
Jul 19, 2011
10:10
Marksans Pharma's director resigns
May 28, 2011
12:14
Marksans Pharma reports net loss of Rs 217.79 crore in the year ended March 2011
Prev
Next
India Infoline Research
Company
|
Sectors
No Related Research Found
Related News
Company
|
Sector
|
Latest
04-Mar-13
Marksans Pharma enters into a settlement agreement with holders of FCCBs
16-Feb-13
Marksans Pharma reports net profit of Rs 7.90 crore in the December 2012 quarter
14-Dec-12
Marksans Pharma allots equity shares
10-Dec-12
Marksans Pharma to consider conversion of warrants
12-Nov-12
Marksans Pharma reports net profit of Rs 14.40 crore in the September 2012 quarter
14-Aug-12
Marksans Pharma reports net loss of Rs 19.73 crore in the June 2012 quarter
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin
34,460.10
27.34
7.11
21.23
23.4
22.7
0.30
Divi's Lab.
13,113.05
21.45
5.14
13.41
27.3
34.1
0.02
Jubilant Life
2,324.98
29.54
1.25
21.18
3.1
6.4
1.43
Shilpa Medicare
699.60
13.97
2.39
9.34
16.3
18.0
0.19
Hikal
668.29
26.19
1.95
5.65
22.4
18.2
1.53
Elder Pharma
584.57
6.35
0.76
6.59
12.9
13.0
1.25
Dishman Pharma.
547.55
11.31
0.81
5.44
6.8
10.2
0.80
Vinati Organics
538.41
7.84
2.23
5.63
33.2
31.3
0.75
Orchid Chemicals
414.25
0.00
0.45
7.67
9.7
8.3
1.75
Shasun Pharma.
411.48
14.93
1.52
7.48
14.0
8.9
1.05
Nectar Lifesci.
356.19
4.16
0.41
6.25
9.7
11.2
1.22
Sequent Scien.
335.72
0.00
2.20
7.62
-3.9
5.9
1.58
Suven Life Scie.
284.41
9.22
1.84
10.21
11.3
9.1
0.64
Aarti Drugs
260.37
5.72
1.25
4.78
13.5
13.7
1.48
Granules India
260.08
8.62
0.96
4.12
11.7
15.2
0.57
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Mark Saldanha , Chairman & Managing Director
Harshavardhan Panigrahi , Company Secretary
Ajay S Joshi , Director
Balwant Shankarrao Desai , Whole-time Director
Company Head Office / Quarters:
11th Floor Lotus Business Park,
Off New Link Road Andheri (W),
Mumbai,
Maharashtra-400053
Phone : 91-22-40012000
Fax : 91-22-40012011/40012099
E-mail :
companysecretary@marksanspharma.com
Web :
http://www.marksanspharma.com
Registrars:
Bigshare Services Pvt Ltd
E-2/3 Ansa Indl Est
Saki Vihar Road
Sakinaka Andheri(E)
Mumbai - 400072
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
No data found
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
Issue Open :
India Finsec
View full month IPO calendar
Economic Events
No economic event today
View full month Economic Events calendar
Results
Bharat Forge | Oil India | Container Corpn.
View full month Results calendar